Nature research paper: SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
Emergence of SARS-CoV-2 variants of concern with progressively increased transmissibility between humans is a threat to global public health. The omicron variant also evades immunity from natural infection or vaccines, but it is unclear whether its exceptional transmissibility is due to immune evasion or intrinsic virological properties.
Kenrie P. Y. Hui, John C. W. Ho, Man-chun Cheung, Ka-chun Ng, Rachel H. H. Ching, Ka-ling Lai, Tonia Tong Kam, Haogao Gu, Leo L. M. Poon, Malik Peiris & Michael C. W. ChanKenrie P. Y. Hui, Leo L. M. Poon, Malik Peiris & Michael C. W. Chan Division of Cardiothoracic Surgery, Department of Surgery, Queen Mary Hospital, Pokfulam, Hong Kong SAR, ChinaDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
T cell responses to SARS-CoV-2 spike cross-recognize Omicron - NatureNature - T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Consulte Mais informação »
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - NatureNature research paper: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Consulte Mais informação »
Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron - NatureNature - Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
Consulte Mais informação »
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipientsA third dose of mRNA vaccine may be necessary to protect recipients of organ transplants from COVID19 and produce effective antibody responses against SARSCoV2, suggests a new immunological analysis of kidney transplant recipients. ScienceTM
Consulte Mais informação »
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - NatureNature research paper: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Consulte Mais informação »